Centiva Capital’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-22,938
Closed -$1.35M 1383
2025
Q2
$1.35M Sell
22,938
-8,610
-27% -$556K 0.02% 488
2025
Q1
$2.31M Buy
31,548
+24,976
+380% +$2.06M 0.07% 149
2024
Q4
$544K Buy
6,572
+911
+16% +$71.8K 0.01% 770
2024
Q3
$405K Sell
5,661
-3,763
-40% -$266K 0.01% 1397
2024
Q2
$645K Sell
9,424
-33,093
-78% -$1.98M 0.01% 1001
2024
Q1
$2.28M Buy
42,517
+29,702
+232% +$1.6M 0.06% 296
2023
Q4
$683K Sell
12,815
-1,848
-13% -$90.1K 0.02% 811
2023
Q3
$728K Buy
14,663
+8,349
+132% +$467K 0.02% 785
2023
Q2
$376K Buy
+6,314
New +$360K 0.01% 986
2022
Q4
Sell
-4,991
Closed -$297K 1461
2022
Q3
$297K Buy
+4,991
New +$301K 0.01% 1047
2022
Q1
Sell
-7,316
Closed -$528K 1697
2021
Q4
$528K Buy
+7,316
New +$531K 0.01% 762
2021
Q3
Sell
-5,455
Closed -$423K 1407
2021
Q2
$423K Buy
+5,455
New +$388K 0.01% 895
2020
Q2
Sell
-15,559
Closed -$662K 720
2020
Q1
$662K Buy
+15,559
New +$769K 0.03% 283

Other funds holding GMED

Centiva Capital's GMED Position: Q3 2025 in Review

Centiva Capital sold out of Globus Medical (GMED) in Q3 2025, closing a stake of 22,938 shares — an estimated $1.35M sold.

Centiva Capital first reported a position in GMED in Q1 2020 and held it in 13 quarters. The position peaked at $2.31M in Q1 2025. 490 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • Centiva Capital reported no remaining Globus Medical position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 22,938 Globus Medical shares in Q3 2025, an estimated $1.35M.
  • Centiva Capital first reported a position in Globus Medical in Q1 2020 and held it in 13 quarters.
  • Centiva Capital's Globus Medical position peaked at $2.31M in Q1 2025.
  • 490 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.